EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ehrlichia Wnt SLiM ligand mimic deactivates the Hippo pathway to engage the anti-apoptotic Yap-GLUT1-BCL-xL axis

Caitlan D Byerly, LaNisha L Patterson, Nicholas A Pittner, Regina N Solomon, Jignesh G Patel, Madison R Rogan, Jere W McBride iD

Infection and Immunity · 14.09.2023 · 91 (9)

DOI: 10.1128/iai.00085-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Immunity, erschienen am 14.09.2023. Verfasst von Caitlan D Byerly und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Medical Branch , Galveston, Texas, USA. Hauptthemen laut MEDLINE: Hippo Signaling Pathway, Ehrlichia chaffeensis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ehrlichia chaffeensis TRP120 effector has evolved short linear motif (SLiM) ligand mimicry to repurpose multiple evolutionarily conserved cellular signaling pathways, including Wnt, Notch, and Hedgehog. In this investigation, we demonstrate that E. chaffeensis and recombinant TRP120 deactivate Hippo signaling, resulting in the activation of Hippo transcription coactivator Yes-associated protein (Yap). Moreover, a homologous 6 amino acid (QDVASH) SLiM shared by TRP120 and Wnt3a/5a ligands phenocopied Yap and β-catenin activation induced by E. chaffeensis, rTRP120, and Wnt5a. Similar Hippo gene expression profiles were also stimulated by E. chaffeensis , rTRP120, SLiM, and Wnt5a. Single siRNA knockdown of Hippo transcription co-activator/factors, Yap, and transcriptional enhanced associate domain (TEAD) significantly decreased E. chaffeensis infection. Yap activation was abolished in THP-1 Wnt Frizzled-5 (Fzd5) receptor knockout cells (KO), demonstrating Fzd5 receptor dependence. In addition, the TRP120-Wnt-SLiM antibody blocked Hippo deactivation (Yap activation). Expression of anti-apoptotic Hippo target gene SLC2A1 (encodes glucose transporter 1; GLUT1) was upregulated by E. chaffeensis and corresponded to increased levels of GLUT1. Conversely, siRNA knockdown of SLC2A1 significantly inhibited infection. Higher GLUT1 levels correlated with increased B cell lymphoma-extra large (BCL-xL) and decreased BCL2-associated X, apoptosis regulator (Bax) levels. Moreover, blocking Yap activation with the inhibitor Verteporfin induced apoptosis that corresponded to significant reductions in GLUT1 and BCL-xL levels and activation of Bax and Caspase-3 and -9. This study identifies a novel shared Wnt/Hippo SLiM ligand mimic and demonstrates that E. chaffeensis deactivates the Hippo pathway to engage the anti-apoptotic Yap-GLUT1-BCL-xL axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hippo Signaling PathwayEhrlichia chaffeensisGlucose Transporter Type 1LigandsApoptosis Regulatory Proteinsbcl-2-Associated X ProteinTranscription Factors

Stichwörter der Autor:innen

EhrlichiaHippo signalingeffectorligandmolecular mimicryshort linear motiftandem repeat protein

Substanzen

Glucose Transporter Type 1LigandsApoptosis Regulatory Proteinsbcl-2-Associated X ProteinTranscription Factors

Autor:innen und Institutionen

  • Department of Pathology, University of Texas Medical Branch , Galveston, Texas, USA.
  • Department of Microbiology and Immunology, University of Texas Medical Branch , Galveston, Texas, USA.
  • Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch , Galveston, Texas, USA.
  • Sealy Institute for Vaccine Sciences, University of Texas Medical Branch , Galveston, Texas, USA.
  • Institute for Human Infections and Immunity, University of Texas Medical Branch , Galveston, Texas, USA.

ORCID-Profile: Jere W McBride

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • HHS | National Institutes of Health

Zitieren

APA

Byerly, C. D., Patterson, L. L., Pittner, N. A., Solomon, R. N., Patel, J. G., Rogan, M. R., & McBride, J. W. (2023). Ehrlichia Wnt SLiM ligand mimic deactivates the Hippo pathway to engage the anti-apoptotic Yap-GLUT1-BCL-xL axis. Infection and Immunity, 91(9). https://doi.org/10.1128/iai.00085-23

Vancouver

Byerly CD, Patterson LL, Pittner NA, Solomon RN, Patel JG, Rogan MR, et al. Ehrlichia Wnt SLiM ligand mimic deactivates the Hippo pathway to engage the anti-apoptotic Yap-GLUT1-BCL-xL axis. Infection and Immunity. 2023;91(9). doi:10.1128/iai.00085-23

BibTeX
@article{Byerly2023,
  author = {Byerly, Caitlan D and Patterson, LaNisha L and Pittner, Nicholas A and Solomon, Regina N and Patel, Jignesh G and Rogan, Madison R and McBride, Jere W},
  title = {Ehrlichia Wnt SLiM ligand mimic deactivates the Hippo pathway to engage the anti-apoptotic Yap-GLUT1-BCL-xL axis},
  journal = {Infection and Immunity},
  year = {2023},
  volume = {91},
  number = {9},
  doi = {10.1128/iai.00085-23}
}
Kostenlos starten →